SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SBC Medical Group Holdings Incorporated (SBC) trades at a trailing P/E of 8.4, forward P/E of 9.6. Trailing earnings yield is 11.86%, forward earnings yield 10.42%. PEG 2.01. Graham Number is $5.36.
Criteria proven by this page:
- VALUE (93/100, Pass) — P/E is below market average (8.4); analyst target implies upside (+106.4%); earnings yield beats bond yields (11.86%).
- PEG Ratio 2.01 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 11.86% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $9.00 (+106.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 87/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
93/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SBC
Valuation Multiples
P/E (TTM)8.4
Forward P/E9.6
PEG Ratio2.01
Forward PEG1.96
P/B Ratio1.73
P/S Ratio2.48
EV/EBITDA4.0
Per Share Data
EPS (TTM)$0.50
Forward EPS (Est.)$0.45
Book Value / Share$2.57
Revenue / Share$1.69
FCF / Share$0.36
Yields & Fair Value
Earnings Yield11.86%
Forward Earnings Yield10.42%
Dividend Yield0.00%
Graham Number$5.36
SharesGrow IV$6.81 (+56.2%)
Analyst Target$9.00 (+106.4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2022 |
24.3 |
0.00 |
1.46 |
0.88 |
- |
| 2023 |
25.8 |
0.02 |
7.16 |
5.26 |
- |
| 2024 |
11.5 |
0.74 |
2.75 |
2.61 |
- |
| 2025 |
8.7 |
2.43 |
1.79 |
2.56 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2022 |
$0.06 |
$174.16M |
$6.32M |
3.6% |
| 2023 |
$0.39 |
$193.54M |
$39.37M |
20.3% |
| 2024 |
$0.48 |
$205.42M |
$46.61M |
22.7% |
| 2025 |
$0.50 |
$173.61M |
$50.99M |
29.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.47 |
$0.46 – $0.48 |
$184.11M |
$179.64M – $188.25M |
2 |
| 2027 |
$0.53 |
$0.51 – $0.55 |
$202.31M |
$197.4M – $206.86M |
2 |
| 2028 |
$0.50 |
$0.48 – $0.51 |
$199.1M |
$189.39M – $208.81M |
1 |
